These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 15042616)
1. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Angelucci A; Festuccia C; Gravina GL; Muzi P; Bonghi L; Vicentini C; Bologna M Prostate; 2004 May; 59(2):157-66. PubMed ID: 15042616 [TBL] [Abstract][Full Text] [Related]
2. Osteopontin: possible role in prostate cancer progression. Thalmann GN; Sikes RA; Devoll RE; Kiefer JA; Markwalder R; Klima I; Farach-Carson CM; Studer UE; Chung LW Clin Cancer Res; 1999 Aug; 5(8):2271-7. PubMed ID: 10473115 [TBL] [Abstract][Full Text] [Related]
3. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins. Lecrone V; Li W; Devoll RE; Logothetis C; Farach-Carson MC Cell Calcium; 2000 Jan; 27(1):35-42. PubMed ID: 10726209 [TBL] [Abstract][Full Text] [Related]
4. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Dorai T; Dutcher JP; Dempster DW; Wiernik PH Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression. Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone. Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275 [TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12. Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238 [TBL] [Abstract][Full Text] [Related]
9. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
10. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014 [TBL] [Abstract][Full Text] [Related]
11. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice. Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332 [TBL] [Abstract][Full Text] [Related]
13. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions. Pavone-Macaluso M; Carruba G; Castagnetta L Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Yan F; Hui YN; Li YJ; Guo CM; Meng H Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892 [TBL] [Abstract][Full Text] [Related]
17. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436 [TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Yano S; Macleod RJ; Chattopadhyay N; Tfelt-Hansen J; Kifor O; Butters RR; Brown EM Bone; 2004 Sep; 35(3):664-72. PubMed ID: 15336602 [TBL] [Abstract][Full Text] [Related]
19. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Jain S; Chakraborty G; Kundu GC Cancer Res; 2006 Jul; 66(13):6638-48. PubMed ID: 16818637 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. Kalli KR; Bradley SV; Fuchshuber S; Conover CA Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]